Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clinica 100: GE Healthcare focuses on organic growth and emerging markets to stay on top

This article was originally published in Clinica

Executive Summary

GE Healthcare has moved up in this year's Clinica 100 ranking from number three to number two in the medtech market, but will need to maintain growth to hold on to its spot. Its strategy includes targeting the emerging markets and focusing on organic growth, among other things, while keeping one eye on bolt-on acquisitions. Madeleine Armstrong spoke to president and CEO of GE Healthcare Europe, Jean-Michel Malbrancq, to find out more

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT098231

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel